Reactive oxygen species and HIF-1 signalling in cancer

Cancer Letters

Volumn 266, Issue 1, 2008, Pages 12-20

  Galanis, Alex ^a   Pappa, Aglaia ^a   Giannakakis, Antonis ^a   Lanitis, Evripidis ^a   Dangaj, Denarda ^a   Sandaltzopoulos, Raphael ^a  

^a Department of Molecular Biology and Genetics ^*  (Greece)

Author keywords

Cancer; ERK MEK; HIF 1 signalling; mTOR; PI3K; PKB Akt; Protein hydroxylation; Reactive oxygen species

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLYCOGEN SYNTHASE KINASE 3BETA; HAMARTIN; HISTONE ACETYLTRANSFERASE PCAF; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OLIGONUCLEOTIDE; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; PROTEIN MDM2; REACTIVE OXYGEN METABOLITE; S6 KINASE; TRANSCRIPTION FACTOR FOXO; TUBERIN;

ANGIOGENESIS; APOPTOSIS; BREAST CANCER; BREAST CARCINOMA; CARCINOGENESIS; CELL CYCLE REGULATION; CELL METABOLISM; DOWN REGULATION; DOWNSTREAM PROCESSING; GENE CONTROL; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HYPOXIA; NONHUMAN; OVARY CANCER; OXYGEN SUPPLY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 44449159236     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.02.028     Document Type: Review

References (56)

1. 2 sensing. Science 292 (2001) 464-468
2. 2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
3. Jeong J.W., Bae M.K., Ahn M.Y., Kim S.H., Sohn T.K., Bae M.H., Yoo M.A., Song E.J., Lee K.J., and Kim K.W. Regulation and destabilization of HIF-1α by ARD1-mediated acetylation. Cell 111 (2002) 709-720
4. Arnesen T., Kong X., Evjenth R., Gromyko D., Varhaug J.E., Lin Z., Sang N., Caro J., and Lillehaug J.R. Interaction between HIF-1[alpha] (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1α. FEBS Lett. 579 (2005) 6428-6432
5. Bilton R., Mazure N., Trottier E., Hattab M., Dery M.A., Richard D.E., Pouyssegur J., and Brahimi-Horn M.C. Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1α and is not induced by hypoxia or HIF. J. Biol. Chem. 280 (2005) 31132-31140
6. Baek J.H., Mahon P.C., Kelly J.B., Krishnamachary B., Pearson M., Chan D.A., Giaccia A.J., and Semenza G.L. OS-9 Interacts with hypoxia-inducible factor 1[alpha] and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1α. Mol. Cell 17 (2005) 503-512
7. Ravi R., Mookerjee B., Bhujwalla Z.M., Sutter C.H., Artemov D., Zeng Q., Dillehay L.E., Madan A., Semenza G.L., and Bedi A. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α 14. Genes Dev. 14 (2000) 34-44
8. Tang T.T., and Lasky L.A. The forkhead transcription factor FOXO4 induces the down-regulation of hypoxia-inducible factor 1α by a von Hippel-Lindau protein-independent mechanism. J. Biol. Chem. 278 (2003) 30125-30135
9. Lando D., Peet D.J., Gorman J.J., Whelan D.A., Whitelaw M.L., and Bruick R.K. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16 (2002) 1466-1471
10. Freedman S.J., Sun Z.Y., Kung A.L., France D.S., Wagner G., and Eck M.J. Structural basis for negative regulation of hypoxia-inducible factor-1α by CITED2. Nat. Struct. Mol. Biol. 10 (2003) 504-512
11. Fox S.B., Braganca J., Turley H., Campo L., Han C., Gatter K.C., Bhattacharya S., and Harris A.L. CITED4 inhibits hypoxia-activated transcription in cancer cells, and its cytoplasmic location in breast cancer is associated with elevated expression of tumor cell hypoxia-inducible factor 1alpha. Cancer Res. 64 (2004) 6075-6081
12. Berta M.A., Mazure N., Hattab M., Pouyssegur J., and Brahimi-Horn M.C. SUMOylation of hypoxia-inducible factor-1α reduces its transcriptional activity. Biochem. Biophys. Res. Commun. 360 (2007) 646-652
13. Bae S.H., Jeong J.W., Park J.A., Kim S.H., Bae M.K., Choi S.J., and Kim K.W. Sumoylation increases HIF-1[alpha] stability and its transcriptional activity. Biochem. Biophys. Res. Commun. 324 (2004) 394-400
14. Hay R.T. SUMO: a history of modification. Mol. Cell 18 (2005) 1-12
15. Guzy R.D., and Schumacker P.T. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp. Physiol. 91 (2006) 807-819
16. 0 site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J. Cell Biol. 177 (2007) 1029-1036
17. Chandel N.S., Maltepe E., Goldwasser E., Mathieu C.E., Simon M.C., and Schumacker P.T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. 95 (1998) 11715-11720
18. 2 sensing. J. Biol. Chem. 275 (2000) 25130-25138
19. Callapina M., Zhou J., Schmid T., Köhl R., Brüne B., et al. NO restores HIF-1α hydroxylation during hypoxia: role of reactive oxygen species. Free Radic. Biol. Med. 39 (2005) 925-936
20. Richard D.E., Berra E., Gothie E., Roux D., and Pouyssegur J. p42/p44 Mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1. J. Biol. Chem. 274 (1999) 32631-32637
21. Mylonis I., Chachami G., Samiotaki M., Panayotou G., Paraskeva E., Kalousi A., Georgatsou E., Bonanou S., and Simos G. Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1α. J. Biol. Chem. 281 (2006) 33095-33106
22. Sang N., Stiehl D.P., Bohensky J., Leshchinsky I., Srinivas V., and Caro J. MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J. Biol. Chem. 278 (2003) 14013-14019
23. Emerling B.M., Platanias L.C., Black E., Nebreda A.R., Davis R.J., and Chandel N.S. Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling. Mol. Cell. Biol. 25 (2005) 4853-4862
24. Shaw R.J., and Cantley L.C. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441 (2006) 424-430
25. Liu L.Z., Hu X.W., Xia C., He J., Zhou Q., Shi X., Fang J., and Jiang B.H. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1α expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic. Biol. Med. 41 (2006) 1521-1533
26. Zhou Q., Liu L.Z., Fu B., Hu X., Shi X., Fang J., and Jiang B.H. Reactive oxygen species regulate insulin-induced VEGF and HIF-1α expression through the activation of p70S6K1 in human prostate cancer cells. Carcinogenesis 28 (2007) 28-37
27. Gao N., Ding M., Zheng J.Z., Zhang Z., Leonard S.S., Liu K.J., Shi X., and Jiang B.H. Vanadate-induced expression of hypoxia-inducible factor 1α and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J. Biol. Chem. 277 (2002) 31963-31971
28. Flugel D., Gorlach A., Michiels C., and Kietzmann T. Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1α and mediates its destabilization in a VHL-Independent manner. Mol. Cell. Biol. 27 (2007) 3253-3265
29. Mottet D., Dumont V., Deccache Y., Demazy C., Ninane N., Raes M., and Michiels C. Regulation of hypoxia-inducible factor-1α protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3{beta} pathway in HepG2 cells. J. Biol. Chem. 278 (2003) 31277-31285
30. Skinner H.D., Zheng J.Z., Fang J., Agani F., and Jiang B.H. Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1α, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling. J. Biol. Chem. 279 (2004) 45643-45651
31. Bardos J.I., Chau N.M., and Ashcroft M. Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor 1α expression. Mol. Cell. Biol. 24 (2004) 2905-2914
32. Brugarolas J.B., Vazquez F., Reddy A., Sellers W.R., and Kaelin W.G. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell 4 (2003) 147-158
33. Sofer A., Lei K., Johannessen C.M., and Ellisen L.W. Regulation of mTOR and cell growth in response to energy stress by RIEDD1. Mol. Cell. Biol. 25 (2005) 5834-5845
34. Mabuchi S., Altomare D.A., Connolly D.C., Klein-Szanto A., Litwin S., Hoelzle M.K., Hensley H.H., Hamilton T.C., and Testa J.R. RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer. Cancer Res. 67 (2007) 2408-2413
35. Gao L.S., Zhang Z., Leonard S., He H., Zhang X.G., Shi X., and Jiang B.H. Arsenite induces HIF-1α and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells. Mol. Cell. Biochem. 255 (2004) 33-45
36. Brown N., and Bicknell R. Hypoxia and oxidative stress in breast cancer: oxidative stress - its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res. 3 (2001) 323-327
37. Chaudary N., and Hill R. Hypoxia and metastasis in breast cancer. Breast Dis. 26 (2006, 2007) 55-64
38. Toi M., Rahman M.A., Bando H., and Chow L.W.C. Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment. Lancet Oncol. 6 (2005) 158-166
39. Laughner E., Taghavi P., Chiles K., Mahon P.C., and Semenza G.L. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21 (2001) 3995-4004
40. Gort E.H., Groot A.J., Derks van de Ven T.L.P., van der Groep P., Verlaan I., van Laar T., van Diest P.J., van der Wall E., and Shvarts A. Hypoxia-inducible factor-1α expression requires PI 3-kinase activity and correlates with Akt1 phosphorylation in invasive breast carcinomas. Oncogene 25 (2006) 6123-6127
41. Bos R., van Diest P.J., de Jong J.S., van der Groep P., van der Valk P., and van der Wall E. Hypoxia-inducible factor-1α is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 46 (2005) 31-36
42. Shi Y., Wang Y., Bingle L., Gong L., Heng W., Li Y., and Fang W. In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways. J. Pathol. 205 (2005) 530-536
43. Berezikov V.G., Belt J., Wienholds E., Plasterk R., and Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120 (2005) 21-24
44. Bentwich I., Avniel A., Karov Y., Aharonov R., Gilad S., Barad O., Barzilai A., et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 37 (2005) 766-770
45. Chen C.Z. MicroRNAs as oncogenes and tumor suppressors. N. Engl. J. Med. 353 (2005) 1768-1771
46. Zamore P.D., and Haley B. Ribo-gnome: the big world of small RNAs. Science 309 (2005) 1519-1524
47. Lewis B.P., Burge C.B., and Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are MicroRNA targets. Cell 120 (2005) 15-20
48. Zhang L., Huang J., Yang N., Greshock J., Megraw M.S., Giannakakis A., Liang S., Naylor T.L., Barchetti A., Ward M.R., Yao G., Medina A., O'Brien-Jenkins A., Katsaros D., Hatzigeorgiou A., Gimotty P.A., Weber B.L., and Coukos G. MicroRNAs exhibit high frequency genomic alterations in human cancer. PNAS 103 (2006) 9136-9141
49. Kulshreshtha R., Ferracin M., Wojcik S.E., Garzon R., Alder H., Agosto-Perez F.J., Davuluri R., Liu C.G., Croce C.M., Negrini M., Calin G.A., and Ivan M. A microRNA signature of hypoxia. Mol. Cell. Biol. 27 (2007) 1859-1867
50. Hebert C., Norris K., Scheper M., Nikitakis N., and Sauk J. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol. Cancer 6 (2007) 5-16
51. Hua Z., Lv Q., Ye W., Wong C.K.A., Cai G., Gu D., Ji Y., Zhao C., Wang J., Yang B.B., and Zhang Y. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE (2006) e116
52. Donker R.B., Mouillet J.F., Nelson D.M., and Sadovsky Y. The expression of argonaute2 and related microRNA biogenesis proteins in normal and hypoxic trophoblasts. Mol. Hum. Reprod. 13 (2007) 273-279
53. Giannakakis A., Coukos G., Sandaltzopoulos R., and Zhang L. miRNA genetic alterations in human cancers. Expert Opin. Biol. Ther. 7 (2007) 1-12
54. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353 (2005) 1793-1801
55. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. PNAS 103 (2006) 2257-2261
56. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., and Stoffel M. Silencing of microRNAs in vivo with antagomirs. Nature 438 (2005) 685-689